- Markets
- Software Services
- JSTL
JSTL
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Jeevan Scientific Technology Says USFDA Conducted Inspection At Bioanalytical Facility At Manikonda
Feb 23 (Reuters) - Jeevan Scientific Technology Ltd JEEV.BO:
USFDA CONDUCTED AN INSPECTION OF OUR BIOANALYTICAL FACILITY, AT MANIKONDA
INSPECTOR CLOSED THE INSPECTION WITH NO 483
Source text for Eikon: ID:nBSE4rL8Mw
Further company coverage: JEEV.BO
(([email protected];))
Feb 23 (Reuters) - Jeevan Scientific Technology Ltd JEEV.BO:
USFDA CONDUCTED AN INSPECTION OF OUR BIOANALYTICAL FACILITY, AT MANIKONDA
INSPECTOR CLOSED THE INSPECTION WITH NO 483
Source text for Eikon: ID:nBSE4rL8Mw
Further company coverage: JEEV.BO
(([email protected];))
Jeevan Scientific Technology Says Unit Entered Into Co-Development Agreement With Aditri Pharma Sciences
Oct 18 (Reuters) - Jeevan Scientific Technology Ltd JEEV.BO:
UNIT ENTERED INTO CO-DEVELOPMENT AGREEMENT WITH ADITRI PHARMA SCIENCES
CO-DEVELOPMENT AGREEMENT TO DEVELOP CERTAIN PHARMACEUTICAL PREPARATIONS ON 50:50 BASIS
Further company coverage: JEEV.BO
(([email protected];))
Oct 18 (Reuters) - Jeevan Scientific Technology Ltd JEEV.BO:
UNIT ENTERED INTO CO-DEVELOPMENT AGREEMENT WITH ADITRI PHARMA SCIENCES
CO-DEVELOPMENT AGREEMENT TO DEVELOP CERTAIN PHARMACEUTICAL PREPARATIONS ON 50:50 BASIS
Further company coverage: JEEV.BO
(([email protected];))
Events:
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Jeevan Scientific do?
Established in 1999, Jeevan Scientific Technology (JSTL) is a leading player in the field of Clinical Research since 2014. It offers quality and cost-effective services to Pharma and Biotech companies worldwide, leveraging technology, innovation, and expertise.
Who are the competitors of Jeevan Scientific?
Jeevan Scientific major competitors are Vivo Bio Tech, Zenotech Laboratorie, Dishman Carbogen Amc, Sun Pharma Adv. Res, Syngene Internation., Suven Life Sciences, Hikal. Market Cap of Jeevan Scientific is ₹67 Crs. While the median market cap of its peers are ₹3,296 Crs.
Is Jeevan Scientific financially stable compared to its competitors?
Jeevan Scientific seems to be less financially stable compared to its competitors. Altman Z score of Jeevan Scientific is 3.51 and is ranked 6 out of its 8 competitors.
Does Jeevan Scientific pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Jeevan Scientific latest dividend payout ratio is 15.11% and 3yr average dividend payout ratio is 15.11%
How has Jeevan Scientific allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Jeevan Scientific balance sheet?
Balance sheet of Jeevan Scientific is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Jeevan Scientific improving?
Yes, profit is increasing. The profit of Jeevan Scientific is ₹0.59 Crs for TTM, -₹1.3 Crs for Mar 2024 and -₹3.05 Crs for Mar 2023.
Is the debt of Jeevan Scientific increasing or decreasing?
The debt of Jeevan Scientific is decreasing. Latest debt of Jeevan Scientific is ₹7.57 Crs as of Sep-24. This is less than Mar-24 when it was ₹10.18 Crs.
Is Jeevan Scientific stock expensive?
Jeevan Scientific is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Jeevan Scientific is 94.87, while 3 year average PE is 49.17. Also latest EV/EBITDA of Jeevan Scientific is 8.5 while 3yr average is 54.9.
Has the share price of Jeevan Scientific grown faster than its competition?
Jeevan Scientific has given better returns compared to its competitors. Jeevan Scientific has grown at ~1.25% over the last 7yrs while peers have grown at a median rate of -4.77%
Is the promoter bullish about Jeevan Scientific?
Promoters seem not to be bullish about the company and have been selling shares in the open market. Latest quarter promoter holding in Jeevan Scientific is 37.84% and last quarter promoter holding is 38.7%
Are mutual funds buying/selling Jeevan Scientific?
There is Insufficient data to gauge this.